SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001333277-19-000020
Filing Date
2019-01-31
Accepted
2019-01-31 17:20:41
Documents
1
Period of Report
2019-01-29

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 3768
  Complete submission text file 0001333277-19-000020.txt   5303
Mailing Address 7575 GATEWAY BOULEVARD SUITE 110 NEWARK CA 94560
Business Address 7575 GATEWAY BOULEVARD SUITE 110 NEWARK CA 94560 510-293-8800
CymaBay Therapeutics, Inc. (Issuer) CIK: 0001042074 (see all company filings)

IRS No.: 943103561 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 161 WEST 61ST STREET NEW YORK NY 10022
Business Address
GOLDFISCHER CARL (Reporting) CIK: 0001110780 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36500 | Film No.: 19556773